LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Study Supports Use of NuVasive Retractor for Prone XLIF Procedures
Spine

Study Supports Use of NuVasive Retractor for Prone XLIF Procedures

November 9, 2020 2 min read Premium comments

Advertisement

Study Supports Use of NuVasive Retractor for Prone XLIF Procedures
MaXcess® Retractor / Courtesy of NuVasive, Inc.
#nuvasiveSecondary#maxcess#xlif

San Diego, California-based NuVasive, Inc. pioneered and patented the extreme lateral interbody fusion (XLIF®) and X360™ procedures and devices. The company is one of the few spine device makers investing in the development of new procedures and devices for those procedures.

A recent study published in The Journal of Neurosurgery: Spine, titled “Single-position prone lateral approach: cadaveric feasibility study and early clinical experience,” has given validation to that effort. The publication features a cadaveric feasibility study and a retrospective analysis of about a dozen patients who were fused using the XLIF procedure while in a prone position.

While the majority of patients received the XLIF implants alone at 1-2 levels, 3 patients also underwent an ALIF (anterior lumbar interbody fusion) at L5-S1, a level that is inaccessible from a lateral approach. One patient required conversion from prone to standard lateral positioning. Retractor time was short at 15 ± 6 minutes per level, on average. Additionally, no intraoperative subsidence was detected.

While not mentioned by name in the study, the company claims that its MaXcess® retractor system was used (images included in the publication show the retractor being used on both cadavers and patients).

Senior Vice President and General Manager of NuVasive’s spine business, Massimo Calafiore, described the impact of the study, saying, “This study adds to the growing body of evidence validating the NuVasive MaXcess retractor’s ability to perform lateral surgery in a variety of approaches, including prone position. Further, it highlights the utility of this approach, as well as its limitations, as not all patients were able to be treated in the prone position, and underscores the value of NuVasive’s X360 system—which offers a complete solution for our surgeon partners.”

Juan Uribe, M.D., chief of the division of spinal disorders at Barrow Neurological Institute in Arizona, explained the importance of prone positioning. He said in a press release from the NuVasive, “Prone positioning for a lateral approach presents an exciting opportunity for streamlining surgical access to the lumbar spine and facilitating a more efficient surgical solution with potential clinical and economic advantages for certain patients…I am grateful for NuVasive’s leadership in developing single-position procedural technologies that support a variety of positions and span the entire patient care continuum.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy